Skip to main content
Novartis
language-selector-globe United Kingdom | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe United Kingdom
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the UK 
      • Partnerships 
        • Collaborative working 
          • The Newcastle upon Tyne Hospitals NHS Foundation Trust 
          • Woodlands Family Medical Centre 
          • Mid Ulster Primary Care Heart Failure 
          • Kingswinford and Wordsley Primary Care Network 
        • External funding 
        • Patient group partnership 
      • Sponsorships 
      • Diseases 
      • Strategy 
      • People and culture 
      • Who we are 
      01077_144dpi_16by9_PPT_RGB About
    • Patients and caregivers 
      • External funding 
      • Patient group partnership 
      • Health coaching video series 
      Doctor and Patient Patients and Caregivers
    • Healthcare professionals 
      • For UK healthcare professionals 
      Healthcare Professional Writing Healthcare Professionals
    • ESG 
      • Ethical behaviour 
        • Code of Ethics 
        • Speakup 
      • Ethics, risk and compliance 
      • Access 
      • Environmental sustainability 
      • Global health 
      • Transparency 
        • Healthcare professional payment transparency 
      • Health inequalities 
      Young girl in doctor's office ESG
    • News 
      • Stories 
      • News archive 
      • Novartis UK press office 
      Professional Colleagues Working Together News
    • Careers 
      • Career search 
      • Personal growth 
      • Early talent 
      • How we work 
      • Well-being 
      • Career programmes 
      • Awards and recognition 
      Novartis building Careers
    • Contact 
    Home Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted Sort ascending
Job Title Site Location Division Business Functional Area Date Posted Sort ascending
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 23, 2024
Study Start-Up Lead Shanghai (Shanghai) China Development Innovative Medicines Research & Development Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
EA & Program Coordinator Beijing (Beijing) China Corporate Affairs Innovative Medicines Communications & Public Affairs Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
(高级)医药代表 /(资深)产品专员 Xining (Qinghai Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
(高级)医药代表 /(资深)产品专员 Urumqi (Xinjiang Province) China International Innovative Medicines Sales Oct 21, 2024
县域主任(主管) Pingdingshan (Henan Province) China International Innovative Medicines Sales Oct 21, 2024
SSO Finance Specialist Shanghai (Shanghai) China Development Innovative Medicines Research & Development Oct 20, 2024
(高级)医药代表 /(资深)产品专员 Ningbo (Zhejiang Province) China International Innovative Medicines Sales Oct 20, 2024
(高级)地区经理 Shenzhen (Guangdong Province) China International Innovative Medicines Sales Oct 20, 2024
Medical Advisor, Ophtha Shanghai (Shanghai) China International Innovative Medicines Research & Development Oct 18, 2024
Medical Advisor, HEMA Shanghai (Shanghai) China International Innovative Medicines Research & Development Oct 18, 2024
(Sr.) Medical Advisor, LC Shanghai (Shanghai) China International Innovative Medicines Research & Development Oct 18, 2024
(高级)地区经理 Huhehaote (Neimenggu Province) China International Innovative Medicines Sales Oct 18, 2024
(高级)地区经理 Chifeng (Neimenggu Province) China International Innovative Medicines Sales Oct 18, 2024
(高级)大区经理 Zhengzhou (Henan Province) China International Innovative Medicines Sales Oct 18, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Oct 18, 2024
(高级)医药代表 /(资深)产品专员 Yangzhou (Jiangsu Province) China International Innovative Medicines Sales Oct 18, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 18, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
(高级)大区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
(高级)医药代表 /(资深)产品专员 Taiyuan (Shanxi Province) China International Innovative Medicines Sales Oct 17, 2024
(高级)医药代表 /(资深)产品专员 Haikou (Hainan Province) China International Innovative Medicines Sales Oct 17, 2024
(高级)医药代表 /(资深)产品专员 Eerduosi (Neimenggu Province) China International Innovative Medicines Sales Oct 17, 2024
(高级)医药代表 /(资深)产品专员 Kunming (Yunnan Province) China International Innovative Medicines Sales Oct 17, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 14
  • › Next page

Novartis UK

Navigate Novartis
  • Patients and caregivers
  • ESG
  • News
  • Careers
Media Center
  • News archive
  • Stories
Our Portfolio
  • Novartis clinical pipeline
  • Novartis product information
Other Novartis Websites
  • Healthcare Professional portal
  • Novartis global
  • Advanced accelerator applications
  • Novartis biome
  • Novartis clinical trials
Footer Bottom
© 2024 Novartis Pharmaceuticals UK Ltd
  • Privacy policy
  • Terms of use
  • Contact
  • Web accessibility
  • Modern slavery statement
  • Cookie settings
Novartis Site Directory
This site is intended for an audience in the UK